Pharmabiz

OrganaBio buys operating assets of Excellos, establishes a coast-to-coast cell therapy contract testing, development and manufacturing organization

OrganaBio buys operating assets of Excellos, establishes a coast-to-coast cell therapy contract testing, development and manufacturing organization: Miami Saturday, May 16, 2026, ...
Pharmabiz

Chengdu Origen, Vanotech receive US FDA’s IND application clearance of KHN921 to treat hypertrophic cardiomyopathy associated with MYBPC3 mutations

Chengdu Origen, Vanotech receive US FDA’s IND application clearance of KHN921 to treat hypertrophic cardiomyopathy associated with MYBPC3 mutations: Chengdu, China Saturday, May ...
Pharmabiz

SN BioScience initiates patient dosing in phase 1b/2 clinical trial of SNB-101 to treat extensive-stage small cell lung cancer

SN BioScience initiates patient dosing in phase 1b/2 clinical trial of SNB-101 to treat extensive-stage small cell lung cancer: Seongnam, South Korea Saturday, May 16, 2026, 17:00 ...
Pharmabiz

BeOne Medicines’ sonrotoclax receives US FDA approval as first and only BCL2 inhibitor for R/R mantle cell lymphoma

BeOne Medicines’ sonrotoclax receives US FDA approval as first and only BCL2 inhibitor for R/R mantle cell lymphoma: San Carlos, California Saturday, May 16, 2026, 14:00 Hrs [IS ...
Pharmabiz

Imperative Care appoints Jay Martin as chief commercial officer

Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, announced the appointment of Jay Martin as chief commercial officer ...
Pharmabiz

Karnataka govt urges pharmacy trade to refrain from AIOCD nationwide strike on May 20

Karnataka govt urges pharmacy trade to refrain from AIOCD nationwide strike on May 20: Nandita Vijayasimha, Bengaluru Saturday, May 16, 2026, 08:00 Hrs [IST] Karnataka government, ...
Pharmabiz

US FDA approves AstraZeneca’s Fasenra for hypereosinophilic syndrome

AstraZeneca’s Fasenra (benralizumab) has been approved by the US FDA for the treatment of adult and paediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) without an ...
Pharmabiz

Panel asks MoA to set up monitoring and implementation mechanism for AOGUSY

Panel asks MoA to set up monitoring and implementation mechanism for AOGUSY: Gireesh Babu, New Delhi Saturday, May 16, 2026, 08:00 Hrs [IST] Raising concerns over the reduction of ...
Pharmabiz

Dyno Therapeutics launches two new AAV Capsids, AI platform for rare disease therapeutic development

Dyno Therapeutics launches two new AAV Capsids, AI platform for rare disease therapeutic development: Watertown, Massachusetts Saturday, May 16, 2026, 13:00 Hrs [IST] Dyno Therape ...
Pharmabiz

TTCDA rallies district units for nationwide pharma bandh, intensifies advocacy against e-pharmacies

TTCDA rallies district units for nationwide pharma bandh, intensifies advocacy against e-pharmacies: Peethaambaran Kunnathoor, Chennai Saturday, May 16, 2026, 08:00 Hrs [IST] At a ...
Pharmabiz

FIEO & Intertek India to convene outreach session on global market access & regulatory compliance on May 21

FIEO & Intertek India to convene outreach session on global market access & regulatory compliance on May 21: Shardul Nautiyal, Mumbai Saturday, May 16, 2026, 09:00 Hrs [IST] In a ...
Pharmabiz

IPC organises scientific conclave and interactive session on Indian Pharmacopoeia 2026 at NIPER, Hyderabad

IPC organises scientific conclave and interactive session on Indian Pharmacopoeia 2026 at NIPER, Hyderabad: Our Bureau, New Delhi Saturday, May 16, 2026, 11:30 Hrs [IST] The India ...